Future Virology. 2014;9(7):633-653. A second-generation L2-based HPV vaccine will face several challenges in reaching the market. Since L1 VLP vaccines are finding widespread application in the ...
Human papillomavirus (HPV) vaccines have long been central to reducing the global incidence of HPV‐associated cancers and benign lesions. Traditional vaccines, based on virus‐like particles (VLPs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results